{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:45:10Z","timestamp":1771461910660,"version":"3.50.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T00:00:00Z","timestamp":1659744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T00:00:00Z","timestamp":1659744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"JSPS KAKENHI"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Artif Organs"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s10047-022-01347-y","type":"journal-article","created":{"date-parts":[[2022,8,6]],"date-time":"2022-08-06T11:03:46Z","timestamp":1659783826000},"page":"184-191","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of the elevated angiopoietin-2 levels during Impella support on the short-term prognosis"],"prefix":"10.1007","volume":"26","author":[{"given":"Makiko","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7294-7637","authenticated-orcid":false,"given":"Teruhiko","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Kinugawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,6]]},"reference":[{"key":"1347_CR1","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1001\/jama.2021.18323","volume":"326","author":"MD Samsky","year":"2021","unstructured":"Samsky MD, Morrow DA, Proudfoot AG, Hochman JS, Thiele H, Rao SV. Cardiogenic shock after acute myocardial infarction: a review. JAMA. 2021;326:1840\u201350.","journal-title":"JAMA"},{"key":"1347_CR2","doi-asserted-by":"publisher","first-page":"e815","DOI":"10.1161\/CIR.0000000000000959","volume":"143","author":"TD Henry","year":"2021","unstructured":"Henry TD, Tomey MI, Tamis-Holland JE, Thiele H, Rao SV, Menon V, Klein DG, Naka Y, Pi\u00f1a IL, Kapur NK, Dangas GD. Invasive management of acute myocardial infarction complicated by cardiogenic shock: a scientific statement from the american heart association. Circulation. 2021;143:e815\u201329.","journal-title":"Circulation"},{"key":"1347_CR3","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1161\/CIRCULATIONAHA.106.613596","volume":"117","author":"HR Reynolds","year":"2008","unstructured":"Reynolds HR, Hochman JS. Cardiogenic shock: current concepts and improving outcomes. Circulation. 2008;117:686\u201397.","journal-title":"Circulation"},{"key":"1347_CR4","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/S0002-9343(00)00310-7","volume":"108","author":"V Menon","year":"2000","unstructured":"Menon V, Slater JN, White HD, Sleeper LA, Cocke T, Hochman JS. Acute myocardial infarction complicated by systemic hypoperfusion without hypotension: report of the SHOCK trial registry. Am J Med. 2000;108:374\u201380.","journal-title":"Am J Med"},{"key":"1347_CR5","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.1161\/01.CIR.0000075927.67673.F2","volume":"107","author":"JS Hochman","year":"2003","unstructured":"Hochman JS. Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. Circulation. 2003;107:2998\u20133002.","journal-title":"Circulation"},{"key":"1347_CR6","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1002\/ejhf.342","volume":"17","author":"J P\u00f6ss","year":"2015","unstructured":"P\u00f6ss J, Fuernau G, Denks D, Desch S, Eitel I, de Waha S, Link A, Schuler G, Adams V, B\u00f6hm M, Thiele H. Angiopoietin-2 in acute myocardial infarction complicated by cardiogenic shock\u2013a biomarker substudy of the IABP-SHOCK II-Trial. Eur J Heart Fail. 2015;17:1152\u201360.","journal-title":"Eur J Heart Fail"},{"key":"1347_CR7","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s00392-014-0787-y","volume":"104","author":"J P\u00f6ss","year":"2015","unstructured":"P\u00f6ss J, Ukena C, Kindermann I, Ehrlich P, Fuernau G, Ewen S, Mahfoud F, Kriechbaum S, B\u00f6hm M, Link A. Angiopoietin-2 and outcome in patients with acute decompensated heart failure. Clin Res Cardiol. 2015;104:380\u20137.","journal-title":"Clin Res Cardiol"},{"key":"1347_CR8","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/ccd.27427","volume":"91","author":"MB Basir","year":"2018","unstructured":"Basir MB, Schreiber T, Dixon S, Alaswad K, Patel K, Almany S, Khandelwal A, Hanson I, George A, Ashbrook M, Blank N, Abdelsalam M, Sareen N, Timmis SBH, O\u2019Neill Md WW. Feasibility of early mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock: the detroit cardiogenic shock initiative. Catheter Cardiovasc Interv. 2018;91:454\u201361.","journal-title":"Catheter Cardiovasc Interv"},{"key":"1347_CR9","doi-asserted-by":"publisher","first-page":"5018","DOI":"10.1172\/JCI99659","volume":"128","author":"SJ Lee","year":"2018","unstructured":"Lee SJ, Lee CK, Kang S, Park I, Kim YH, Kim SK, Hong SP, Bae H, He Y, Kubota Y, Koh GY. Angiopoietin-2 exacerbates cardiac hypoxia and inflammation after myocardial infarction. J Clin Invest. 2018;128:5018\u201333.","journal-title":"J Clin Invest"},{"key":"1347_CR10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/nyas.12726","volume":"1347","author":"A Scholz","year":"2015","unstructured":"Scholz A, Plate KH, Reiss Y. Angiopoietin-2: a multifaceted cytokine that functions in both angiogenesis and inflammation. Ann N Y Acad Sci. 2015;1347:45\u201351.","journal-title":"Ann N Y Acad Sci"},{"key":"1347_CR11","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1093\/eurjhf\/hft117","volume":"15","author":"R Lorbeer","year":"2013","unstructured":"Lorbeer R, Baumeister SE, D\u00f6rr M, Nauck M, Grotevendt A, V\u00f6lzke H, Vasan RS, Wallaschofski H, Lieb W. Circulating angiopoietin-2, its soluble receptor Tie-2, and mortality in the general population. Eur J Heart Fail. 2013;15:1327\u201334.","journal-title":"Eur J Heart Fail"},{"key":"1347_CR12","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1177\/1741826710389410","volume":"18","author":"E Eleuteri","year":"2011","unstructured":"Eleuteri E, Di Stefano A, Tarro Genta F, Vicari C, Gnemmi I, Colombo M, Mezzani A, Giannuzzi P. Stepwise increase of angiopoietin-2 serum levels is related to haemodynamic and functional impairment in stable chronic heart failure. Eur J Cardiovasc Prev Rehabil. 2011;18:607\u201314.","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"1347_CR13","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1093\/eurheartj\/ehs487","volume":"34","author":"A Link","year":"2013","unstructured":"Link A, Poss J, Rbah R, Barth C, Feth L, Selejan S, Bohm M. Circulating angiopoietins and cardiovascular mortality in cardiogenic shock. Eur Heart J. 2013;34:1651\u201362.","journal-title":"Eur Heart J"},{"key":"1347_CR14","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1161\/CIRCULATIONAHA.115.019692","volume":"134","author":"CE Tabit","year":"2016","unstructured":"Tabit CE, Chen P, Kim GH, Fedson SE, Sayer G, Coplan MJ, Jeevanandam V, Uriel N, Liao JK. Elevated angiopoietin-2 level in patients with continuous-flow left ventricular assist devices leads to altered angiogenesis and is associated with higher nonsurgical bleeding. Circulation. 2016;134:141\u201352.","journal-title":"Circulation"}],"container-title":["Journal of Artificial Organs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10047-022-01347-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10047-022-01347-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10047-022-01347-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T04:07:11Z","timestamp":1691726831000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10047-022-01347-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,6]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["1347"],"URL":"https:\/\/doi.org\/10.1007\/s10047-022-01347-y","relation":{},"ISSN":["1434-7229","1619-0904"],"issn-type":[{"value":"1434-7229","type":"print"},{"value":"1619-0904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,6]]},"assertion":[{"value":"16 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Clinical Research Review Board, University of Toyama, IRB number R2015154.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}